The future of pharmaceuticals in India: Analyzing patent law's influence on generic drug availability

Abstract

Access to essential medicines remains a significant challenge, particularly in low- and middle-income countries, where high costs due to patent protections hinder the availability of affordable generic drugs. This paper examines the relationship between patent law and the accessibility of generic medications, emphasizing the necessity for reform. Through a comparative analysis of international case studies-including India, South Africa, Brazil, and the United States-we explore the impact of various patent regulations on generic drug access. The findings reveal that while patent laws are designed to foster innovation, they often inadvertently restrict access to lifesaving medicines. We highlight successful strategies, such as compulsory licensing and public health-oriented patent legislation, that have effectively increased the availability of generics. The paper concludes with policy recommendations aimed at balancing the interests of pharmaceutical innovation with the urgent need for equitable access to medicines, underscoring the critical role of comprehensive patent law reform in achieving this goal.